Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligence
Most of the current utilization of liquid biopsy (LBx) is based on analyzing cell-free DNA(cfDNA). There is limited data on using cell-free RNA (cfRNA) levels (liquid transcriptome) in LBx. The major hurdles for using liquid transcriptome is its low level in circulation and the dilutional effects of...
Saved in:
| Main Authors: | Maher Albitar, Ahmad Charifa, Sally Agersborg, Andrew Pecora, Andrew Ip, Andre Goy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | The Journal of Liquid Biopsy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295019542400136X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma
by: Ligia Gabriela Tataranu
Published: (2025-04-01) -
Liquid Biopsy-Based DNA Methylation Biomarkers for Precision Medicine in Breast Cancer
by: Ieva Sadzeviciene, et al.
Published: (2025-01-01) -
Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System
by: Shivaprasad H. Sathyanarayana, et al.
Published: (2025-07-01) -
Peak analysis of cell-free RNA finds recurrently protected narrow regions with clinical potential
by: Pengfei Bao, et al.
Published: (2025-05-01) -
Comprehensive evaluation of methods for identifying tissues or cell types of origin of the plasma cell-free transcriptome
by: Tingyu Yang, et al.
Published: (2025-04-01)